Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Wisconsin

Phase 1 cancer trials in Wisconsin

59 Phase 1 cancer studies are recruiting participants at sites in 3 cities across Wisconsin as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Wisconsin city with a recruiting study

By research area: Lymphoma (19), Breast Cancer (14), Prostate Cancer (10), Lung Cancer (8), Pancreatic Cancer (7), Melanoma (1).

Madison (32), Milwaukee (30), Marshfield (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Wisconsin

Basic details from each study's public record (the 12 most recently updated of 59). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Madison
    Registry record
    NCT07488676 · updated
  2. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Recruiting in
    Madison · Milwaukee
    Registry record
    NCT06638307 · updated
  3. A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Recruiting in
    Madison
    Registry record
    NCT06827236 · updated
  4. A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Madison
    Registry record
    NCT07213791 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Lung cancer: recently updated in Wisconsin

  1. Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Recruiting in
    Milwaukee
    Registry record
    NCT04198766 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Prostate cancer: recently updated in Wisconsin

  1. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    • Phase 1
    • Ages 18 to 100
    • Male participants
    Sponsor
    Janux Therapeutics
    Recruiting in
    Madison · Milwaukee
    Registry record
    NCT05519449 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Melanoma: recently updated in Wisconsin

  1. Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Wisconsin, Madison
    Recruiting in
    Madison
    Registry record
    NCT07281924 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Wisconsin on ClinicalTrials.gov.

Lymphoma: recently updated in Wisconsin

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Recruiting in
    Madison · Marshfield
    Registry record
    NCT04726241 · updated
  2. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Milwaukee
    Registry record
    NCT07101328 · updated
  3. A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Milwaukee
    Registry record
    NCT07226843 · updated
  4. Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Veronika Bachanova
    Recruiting in
    Madison
    Registry record
    NCT03681561 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Wisconsin on ClinicalTrials.gov.

Pancreatic cancer: recently updated in Wisconsin

  1. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Madison
    Registry record
    NCT05372614 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Ask about studies in Wisconsin

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call